Evidence map›Paper›PMID 38920373›Full record

ArticlemSystems2024

Phenotypic resistant single-cell characteristics under recurring ampicillin antibiotic exposure in

Silvia Kollerová, Lionel Jouvet, Julia Smelková, Sara Zunk-Parras, Alexandro Rodríguez-Rojas, Ulrich K Steiner

Abstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Contributions of intra- and extracellular antibiotic degradation to collective [Formula: see text]-lactam survival.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Silvia KollerováDepartment of Biology, University of Southern Denmark, Odense, Denmark.
Lionel JouvetDepartment of Biology, University of Southern Denmark, Odense, Denmark.
Julia SmelkováDepartment of Biology, University of Southern Denmark, Odense, Denmark.
Sara Zunk-ParrasBiological Institute, Freie Universität Berlin, Berlin, Germany.
Alexandro Rodríguez-RojasBiological Institute, Freie Universität Berlin, Berlin, Germany.ORCID 0000-0002-4119-8127
Ulrich K SteinerDepartment of Biology, University of Southern Denmark, Odense, Denmark.ORCID 0000-0002-1778-5989

Funding

Deutsche Forschungsgemeinschaft (DFG) 430170797Deutsche Forschungsgemeinschaft (DFG) 430174701
6 · The paper itself

Abstract

Non-heritable, phenotypic drug resistance toward antibiotics challenges antibiotic therapies. Characteristics of such phenotypic resistance have implications for the evolution of heritable resistance. Diverse forms of phenotypic resistance have been described, but phenotypic resistance characteristics remain less explored than genetic resistance. Here, we add novel combinations of single-cell characteristics of phenotypic resistant IMPORTANCE: Antibiotic resistance is a major challenge for modern medicine. Aside from genetic resistance to antibiotics, phenotypic resistance that is not heritable might play a crucial role for the evolution of antibiotic resistance. Using a highly controlled microfluidic system, we characterize single cells under recurrent exposure to antibiotics. Fluctuating antibiotic exposure is likely experienced under common antibiotic therapies. These phenotypic resistant cell characteristics differ from previously described phenotypic resistance, highlighting the diversity of modes of resistance. The phenotypic characteristics of resistant cells we identify also imply that such cells might provide a stepping stone toward genetic resistance, thereby causing treatment failure.

Indexed as

AmpicillinAnti-Bacterial AgentsDrug Resistance, BacterialEscherichia coliPhenotypeSingle-Cell AnalysisMicrobial Sensitivity TestsAmpicillinAnti-Bacterial Agentsantibiotic resistancemicrofluidicspersistencephenotypic resistancesingle-celltoleranceβ-lactam antibiotics

Identifiers

PMID38920373
PMCPMC11264686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.